carbon monoxide
Small moleculeexperimental
Carbon monoxide is a poisonous, flammable gas that is colorless, odorless, tasteless, and slightly less dense than air. Carbon monoxide consists of one carbon atom and one oxygen atom connected by a triple bond. It is the simplest carbon oxide. In coordination complexes, the carbon monoxide ligand is called carbonyl. It is a key ingredient in many processes in industrial chemistry. — Wikipedia
Clinical trial activity
26 trials · 32 clinical orgs · 0 marketing orgs
Phase 1
12
Phase 2
10
Phase 3
0
Phase 4
0
Earliest trial started Oct 13, 2004 (NCT00094406)
Timeline
Indications
Studied for
- Anemia, Sickle Cell · Phase 1/Phase 2
- Carbon Monoxide · Phase 1/Phase 2
- Endothelial Cells · Phase 1
- Healthy Volunteers · Phase 1
- Heart Diseases · Phase 1/Phase 2
- Hypertension, Pulmonary · Phase 1/Phase 2
- Idiopathic Pulmonary Fibrosis · Phase 2
- Ileus · Phase 2
- Kidney Transplantation · Phase 2
- Organelle Biogenesis · Phase 1/Phase 2
- Pancreatitis, Chronic · Phase 1/Phase 2
- Parkinson Disease · Phase 2
- Pulmonary Diffusing Capacity · Phase 1
- Pulmonary Disease, Chronic Obstructive · Phase 2
- Respiratory Distress Syndrome · Phase 2
- Sepsis · Phase 1
- Smoking · Phase 1
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
[C-]#[O+]- Mol. weight
- 28.01 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaCarbon monoxide ↗
- ChEMBLCHEMBL1231840 ↗
- WikipediaCO ↗
Also known as
- carboneum oxygenisatum
- carboneum oxygenisatum
- carbon(ii) oxide
- carbon(ii) oxide
- carbon monoxide
- carbon monoxide
- carbon monoxide
- carbon monoxide
- co
- co
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07005180 | Phase 2 | Aug 31, 2025 | Hillhurst Biopharmaceuticals, Inc. |
| NCT06763536 | N/A | Jun 13, 2025 | National Cancer Institute (NCI), Ohio State University |
| NCT06144749 | Phase 1/Phase 2 (Phase 2) | Jan 8, 2024 | Hillhurst Biopharmaceuticals, Inc., National Heart, Lung, and Blood Institute (NHLBI) |
| NCT04870125 | Phase 1 | Sep 30, 2022 | Cornell University, Duke University, Harvard University, National Heart, Lung, and Blood Institute (NHLBI), Washington University in St. Louis |
| NCT04679402 | N/A | Nov 1, 2021 | Case Western Reserve University, Duke University |
| NCT04928183 | N/A | Jun 10, 2021 | University of Alberta |
| NCT03926819 | Phase 1 | Dec 31, 2019 | Hillhurst Biopharmaceuticals, Inc., National Heart, Lung, and Blood Institute (NHLBI) |
| NCT03799874 | Phase 2 | Jan 31, 2019 | Cornell University, Department of Veteran Affairs, Duke University, Harvard University, United States Army, Washington University in St. Louis |
| NCT03385174 | N/A | Oct 1, 2017 | University of Copenhagen |
| NCT03166787 | Phase 1 | Jul 15, 2017 | Cedars-Sinai Medical Center, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH) |
| NCT03067701 | Phase 1 | Mar 13, 2017 | Cedars-Sinai Medical Center |
| NCT03075020 | N/A | Oct 31, 2016 | University of Copenhagen |
| NCT02425579 | Phase 1 | Apr 1, 2015 | Cornell University, Duke University, Harvard University |
| NCT02567240 | Phase 1/Phase 2 (Phase 2) | Jan 31, 2015 | Medical University of South Carolina |
| NCT02066558 | N/A | Feb 28, 2014 | University of Copenhagen |
| NCT01727167 | Phase 1/Phase 2 (Phase 2) | Feb 1, 2014 | Duke University |
| NCT02032082 | N/A | Jan 31, 2014 | CHU Mont-Godinne |
| NCT01523548 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2012 | National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), University of Illinois at Chicago |
| NCT01818843 | N/A | Apr 30, 2012 | People's Liberation Army of China |
| NCT01214187 | Phase 2 | Jul 1, 2011 | Columbia University, Harvard University, National Heart, Lung, and Blood Institute (NHLBI), Tulane University, University of California, San Francisco, University of Chicago, University of Illinois at Chicago, University of Michigan, University of Washington |
Showing 20 of 26 trials
Page 1 / 2
Organizations
Research & Development (32)
32 organizations
Page 1 / 2